Published in Lab Business Week, July 17th, 2005
M. Urquiza and colleagues at the Foundation Institute of Immunology of Colombia "found that peptides 18283 ((55)PNNNKILVPKVSGLQYRVFR(74)) and 18294 ((284)LYIKGSGSTANLASSNYFPT(300)) from the L1-surface exposed regions were specifically recognized by antibodies from the cervical lesion patient sera. These peptides were tested...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.